ULBP2 and neoplasm: IHC staining revealed a significant increase in the number of CD8+ T cells in the ULBP2 CAR-T cell-treated mice compared with that in the control mice, and co-treatment with anti-PD-1 further enhanced the infiltration of cytotoxic T cells into the tumor (Fig. 7E, G).